A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Rituximab in Patients with Previously Untreated Chronie Lymphocytic Leukemia with 17p Deletion
Clinical Trial Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Gilead Sciences, Inc.
Start Date
November 10, 2014
End Date
November 9, 2019
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Gilead Sciences, Inc.
Start Date
November 10, 2014
End Date
November 9, 2019